```json
{
"content": [
{
"type": "paragraph",
"content": "The Endoscope + Radiofrequency Ablation (RFA) market combines minimally invasive diagnostic and therapeutic technologies, primarily used for treating gastrointestinal disorders, Barrett’s esophagus, and early-stage cancers. This Endoscope + RFA market size was valued at USD 1.8 billion in 2025, reflecting robust growth outlook due to rising demand for less invasive procedures and advancements in precision medicine. The market forecast projects a CAGR of 6.2% through 2033, fueled by aging populations and expanding applications in urology and pulmonology. Industry expansion is further driven by technological innovations in imaging and ablation systems, along with favorable reimbursement policies in high-income regions."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Flexible Endoscopes", "Rigid Endoscopes", "Capsule Endoscopes"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[900, 950, 1020, 1100, 1180, 1270, 1360, 1460, 1570, 1690, 1820, 1960, 2110], // Flexible
[400, 410, 420, 430, 440, 450, 460, 470, 480, 490, 500, 510, 520], // Rigid
[150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 270] // Capsule
]
}
},
{
"type": "paragraph",
"content": "Key forces shaping the Endoscope + RFA industry include AI-driven imaging enhancements in flexible endoscopes, which are dominating market share, and regulatory shifts prioritizing patient safety in ablation protocols. North America remains the largest regional market, leveraging its advanced healthcare infrastructure and high RFA adoption rates. Meanwhile, Asia-Pacific is the fastest-growing region, propelled by rising healthcare expenditures and increasing prevalence of lifestyle-related diseases. Competitive intensity is rising as manufacturers invest in R&D to differentiate offerings through automation and hybrid device platforms."
}
]
}
```
